Navigation Links
Limited transparency in federal nanotech research may hamper development
Date:4/16/2008

Washington, DC Without clear leadership and more transparency in federal risk research investment, the emergence of safe nanotechnologies will be a happy accident, rather than a foregone conclusion, says Dr. Andrew Maynard, the Chief Science Advisor for the Project on Emerging Nanotechnologies (PEN). This sentiment was voiced today by Dr. Maynard in testimony at the House Science & Technology Committees hearing on the National Nanotechnology Initiative Amendments Act of 2008.

Activities to date within the federal nanotechnology initiative have been less than transparent, to the detriment of an effective strategy for nanotechnology development and use, Dr. Maynard says in written testimony submitted to the committee. There is a yawning knowledge-gap between nanomaterials entering commerce now and what we know about their safety. This uncertainty over how to develop nanotechnologies safely is hamstringing regulators, impeding nano businesses, and confusing consumers. In short, moving towards the nanotechnology future without a clear understanding of the possible risks, and how to manage them, is like driving blindfolded.

A PEN assessment of purported nanotechnology risk-relevant research published by the federal governments National Nanotechnology Initiative reveals that spending on environment, health and safety-focused research projects in 2006 was substantially lower than that claimed by U.S. officials.

Research projects with the primary aim of understanding and managing the risks of nanotechnology accounted for only $13 million in funding for 2006, according to Dr. Maynard. Over the same period, European Union nations invested nearly $24 million in similar nanotech risk-focused projectsalmost twice as much as the U.S. There is undoubtedly potentially-relevant research buried in other U.S. government funded projects. But without transparency, it is impossible to assess the true value of this research, or ensure it is used to enable the development of safe nanotechnologies.

In his testimony Dr. Maynard also renews calls for a reorganization of a federal nanotechnology risk research strategy that emphasizes a top-down approach to directing environment, health and safety studies on the cutting-edge technology; urges a minimum of 10 percent of the federal nanotechnology research budget be committed to highly or substantially relevant environmental, health and safety topics a significant increase from current levels; and the creation of public-private partnerships that will leverage more funding for research.

On top of discussing issues pertaining to the federal investment in nanotechnology research, Dr. Maynard addresses his concern with the nano-readiness of Americas students, teachers and workforce in his testimony particularly through his endorsement of initiatives aimed at recruiting and preparing students to pursue education in nanotechnology. The House nanotechnology legislation at issue focuses significant attention on nanotechnology education.

When today China has as many scientists and engineers working on nanotechnology as the U.S., it is critical to support initiatives in nanotechnology education aimed at our young people, Dr. Maynard says.


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology technology :

1. Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement
2. Daval International Limited Gains Approval for Phase IIB Trial of AIMSPRO(R)
3. Sunrise Biotech Holding Limited Application For Admission to PLUS
4. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
5. Slow federal action to oversee nanotechnology leaves room at the bottom
6. Hepatitis B Foundation Testifies Before Congressional Appropriation Committee and Urges More Federal Funding for Hepatitis B
7. Federal nanotech risk research plan still comes up short
8. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
9. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem
10. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
11. Zimmer Announces Settlement of Federal Investigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... YORK , Feb. 11, 2016  Bioethics International, a ... medicines are researched, developed, marketed and made accessible to patients ... BMJ Open had named the publication of the ... 2015. The publication is also featured as one of ... in the last year that are most frequently read. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... dedicated to delivering cutting-edge information focused on the development and manufacture of ... become a premier sponsor of the 2016 BioProcess International Awards – Recognizing ...
(Date:2/11/2016)...   BioInformant announces the February 2016 release ... Opportunities, Tools, and Technologies – Market Size, Segments, Trends, ... The first and only market ... BioInformant has more than a decade of historical information ... stem cell type. This powerful 175 page global strategic ...
(Date:2/11/2016)... ... 2016 , ... Global Stem Cells Group, has ... The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine, ... , The new GSCG clinic is headed by four prominent Ecuadorian physicians, including ...
Breaking Biology Technology:
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
(Date:1/25/2016)... 2016   Unisys Corporation (NYSE: UIS ) today ... (JFK) International Airport, New York City , to ... attempting to enter the United States using ... pilot testing of the system at Dulles last year. ... JFK during January 2016. --> pilot testing of ...
(Date:1/20/2016)... 20, 2016 A market that just keeps ... from the explosion in genomics knowledge. Learn all about ... A range of dynamic trends are pushing market growth ... medicine - pharmacogenomics - pathogen evolution - next generation ... - greater understanding of the role of genetic material ...
Breaking Biology News(10 mins):